Home// - Proper Dosing for Effective Treatment of Hemolytic Disease of the Fetus and Newborn (HDFN) in Afric
Are you sure you want to exit?
Any unsave changes will be lost.
Proper Dosing for Effective Treatment of Hemolytic Disease of the Fetus and Newborn (HDFN) in Afric
The Governing Council of the University of Toronto
Category
Reproductive Services
Country
Egypt
Description
The University of Toronto is developing and testing an easy-to-use automated instrument for counting fetal and maternal red blood cells to enable proper dosing of RhoGAM for the treatment of Hemolytic Disease of the Fetus and Newborn